These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35151335)
1. ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14. Zhang Y; Sun M; Gao L; Liang X; Ma C; Lu J; Yue X Cancer Cell Int; 2022 Feb; 22(1):76. PubMed ID: 35151335 [TBL] [Abstract][Full Text] [Related]
2. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1. Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330 [TBL] [Abstract][Full Text] [Related]
3. S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway. Jiang S; Zhu Y; Chen Z; Huang Z; Liu B; Xu Y; Li Z; Lin Z; Li M Hum Cell; 2021 Jul; 34(4):1215-1226. PubMed ID: 33890248 [TBL] [Abstract][Full Text] [Related]
4. Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E. Yue X; Zhang Z; Liang X; Gao L; Zhang X; Zhao D; Liu X; Ma H; Guo M; Spear BT; Gong Y; Ma C Gastroenterology; 2012 Jun; 142(7):1559-70.e2. PubMed ID: 22406477 [TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake. Wu Z; Ma H; Wang L; Song X; Zhang J; Liu W; Ge Y; Sun Y; Yu X; Wang Z; Wang J; Zhang Y; Li C; Li N; Gao L; Liang X; Yue X; Ma C Cell Death Differ; 2020 May; 27(5):1693-1708. PubMed ID: 31740790 [TBL] [Abstract][Full Text] [Related]
6. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation. Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388 [TBL] [Abstract][Full Text] [Related]
7. Zinc fingers and homeoboxes 2 inhibition could suppress the proliferation of ovarian cancer cells by apoptosis pathway. Ding R; Shi H; Guo Y; Zeng W; Fan J Clin Transl Oncol; 2023 Jul; 25(7):2116-2126. PubMed ID: 36746874 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma. Ding F; Wang D; Li XK; Yang L; Liu HY; Cui W; Liu ZH; Che YQ Thorac Cancer; 2018 Jul; 9(7):827-835. PubMed ID: 29733545 [TBL] [Abstract][Full Text] [Related]
9. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion. Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418 [TBL] [Abstract][Full Text] [Related]
10. Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis. Hu S; Zhang M; Lv Z; Bi J; Dong Y; Wen J Neoplasma; 2007; 54(3):207-11. PubMed ID: 17447851 [TBL] [Abstract][Full Text] [Related]
11. The transcription factor zinc fingers and homeoboxes 2 alleviates NASH by transcriptional activation of phosphatase and tensin homolog. Zhao Y; Gao L; Jiang C; Chen J; Qin Z; Zhong F; Yan Y; Tong R; Zhou M; Yuan A; Pu J Hepatology; 2022 Apr; 75(4):939-954. PubMed ID: 34545586 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer. Cheng A; Guo X; Dai X; Wang Z FEBS Open Bio; 2021 Jun; 11(6):1785-1798. PubMed ID: 33837660 [TBL] [Abstract][Full Text] [Related]
13. ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma. Zhu L; Ding R; Yan H; Zhang J; Lin Z Cell Death Dis; 2020 May; 11(5):337. PubMed ID: 32382017 [TBL] [Abstract][Full Text] [Related]
14. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p. Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma. Katono K; Sato Y; Kobayashi M; Saito K; Nagashio R; Ryuge S; Igawa S; Nakashima H; Shiomi K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Masuda N Oncol Res Treat; 2017; 40(10):594-602. PubMed ID: 28950283 [TBL] [Abstract][Full Text] [Related]
16. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis. Li X; Wang M; Gong T; Lei X; Hu T; Tian M; Ding F; Ma F; Chen H; Liu Z Theranostics; 2020; 10(13):5687-5703. PubMed ID: 32483412 [No Abstract] [Full Text] [Related]
17. S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells. Wang X; Yang J; Qian J; Liu Z; Chen H; Cui Z Am J Cancer Res; 2015; 5(4):1484-95. PubMed ID: 26101712 [TBL] [Abstract][Full Text] [Related]
18. Significance of a calcium-binding protein S100A14 expression in colon cancer progression. Hashida H; Coffey RJ J Gastrointest Oncol; 2022 Feb; 13(1):149-162. PubMed ID: 35284114 [TBL] [Abstract][Full Text] [Related]
19. ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway. Tian X; Wang Y; Li S; Yue W; Tian H Cancer Biomark; 2020; 27(1):75-84. PubMed ID: 31683461 [TBL] [Abstract][Full Text] [Related]
20. ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA. Ma H; Yue X; Gao L; Liang X; Yan W; Zhang Z; Shan H; Zhang H; Spear BT; Ma C Oncotarget; 2015 Jan; 6(2):1049-63. PubMed ID: 25473899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]